» Articles » PMID: 21131318

Host Range of Enterococcal VanA Plasmids Among Gram-positive Intestinal Bacteria

Overview
Date 2010 Dec 7
PMID 21131318
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The most prevalent type of acquired glycopeptide resistance is encoded by the vanA transposon Tn1546 located mainly on transferable plasmids in Enterococcus faecium. The limited occurrence in other species could be due to the lack of inter-species transferability and/or stability of Tn1546-containing plasmids in other species. We investigated the in vitro transferability of 14 pre-characterized vanA-containing plasmids hosted by E. faecium (n = 9), Enterococcus faecalis (n = 4) and Enterococcus raffinosus (n = 1) into several enterococcal, lactobacterial, lactococcal and bifidobacterial recipients.

Methods: A filter-mating protocol was harmonized using procedures of seven partner laboratories. Donor strains were mated with three E. faecium recipients, three E. faecalis recipients, a Lactobacillus acidophilus recipient, a Lactococcus lactis recipient and two Bifidobacterium recipients. Transfer rates were calculated per donor and recipient. Transconjugants were confirmed by determining their phenotypic and genotypic properties. Stability of plasmids in the new host was assessed in long-term growth experiments.

Results: In total, 282 enterococcal matings and 73 inter-genus matings were performed and evaluated. In summary, intra-species transfer was far more frequent than inter-species transfer, if that was detectable at all. All recipients of the same species behaved similarly. Inter-genus transfer was shown for broad host range control plasmids (pIP501/pAMβ1) only. Acquired resistance plasmids remained stable in the new host.

Conclusions: Intra-species transfer of enterococcal vanA plasmids was far more frequent than transfer across species or genus barriers and may thus explain the preferred prevalence of vanA-containing plasmids among E. faecium. A reservoir of vanA plasmids in non-enterococcal intestinal colonizers does not seem to be reasonable.

Citing Articles

Enterococcus faecium: evolution, adaptation, pathogenesis and emerging therapeutics.

Wei Y, Palacios Araya D, Palmer K Nat Rev Microbiol. 2024; 22(11):705-721.

PMID: 38890478 DOI: 10.1038/s41579-024-01058-6.


Vancomycin Resistance in Enterococcus faecium from the Dallas, Texas, Area Is Conferred Predominantly on pRUM-Like Plasmids.

Islam M, Sharon B, Abaragu A, Sistu H, Akins R, Palmer K mSphere. 2023; 8(2):e0002423.

PMID: 36939336 PMC: 10117061. DOI: 10.1128/msphere.00024-23.


Multidrug-Resistant Enterococcal Infection in Surgical Patients, What Surgeons Need to Know.

Farsi S, Salama I, Escalante-Alderete E, Cervantes J Microorganisms. 2023; 11(2).

PMID: 36838203 PMC: 9968095. DOI: 10.3390/microorganisms11020238.


Genomic Surveillance of Vancomycin-Resistant Enterococcus faecium Reveals Spread of a Linear Plasmid Conferring a Nutrient Utilization Advantage.

Boumasmoud M, Dengler Haunreiter V, Schweizer T, Meyer L, Chakrakodi B, Schreiber P mBio. 2022; 13(2):e0377121.

PMID: 35343787 PMC: 9040824. DOI: 10.1128/mbio.03771-21.


Antimicrobial Peptides as an Alternative for the Eradication of Bacterial Biofilms of Multi-Drug Resistant Bacteria.

de Pontes J, Toledo Borges A, Roque-Borda C, Pavan F Pharmaceutics. 2022; 14(3).

PMID: 35336016 PMC: 8950055. DOI: 10.3390/pharmaceutics14030642.